Novel gallium(III) complexes transported by MDR1 P-glycoprotein: Potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo

Chemistry and Biology

Volumn 7, Issue 5, 2000, Pages 335-343

  Sharma, V ^a   Beatty, A ^b   Wey, S P ^c   Dahlheimer, J ^a   Pica, C M ^a   Crankshaw, C L ^a   Bass, L ^a   Green, M A ^c   Welch, M J ^a   Piwnica Worms, D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Gallium complexes; Molecular imaging; Multidrug resistance; P glycoprotein; Positron emission tomography

Indexed keywords

CRYSTAL STRUCTURE; GALLIUM COMPLEX; GENE DISRUPTION; GENE THERAPY; IN VIVO STUDY; MDR1 P GLYCOPROTEIN; MOUSE; MULTIDRUG RESISTANCE; POSITRON EMISSION TOMOGRAPHY; PROTEIN FOLDING; PROTEIN TRANSPORT; TUMOR CELL;

EID: 0034087507     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)00111-3     Document Type: Article

References (46)

1. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:1993;385-427.
2. Bosch I., Croop J. P-glycoprotein multidrug resistance and cancer. Biochim. Biophys. Acta. 1288:1996;F37-F54.
3. Gros P., Ben Neriah Y., Croop J.M., Housman D.E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 323:1986;728-731.
4. Shen D.W., Gottesman M.M.et al. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science. 232:1986;643-645.
5. Sorrentino B., Nienhuis A.et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science. 257:1992;99-103.
6. Podda S., Bank A.et al. Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Natl Acad. Sci. USA. 89:1992;9676-9680.
7. Hanania E., Fu S., Roninson I., Zu Z., Gottesman M., Deisseroth A. Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit. Gene Ther. 2:1995;279.
8. Homolya L., Hollo Z., Germann U.A., Pastan I., Gottesman M.M., Sarkadi B. Fluorescent cellular indicators are extruded by the multidrug resistance protein. J. Biol. Chem. 268:1993;21493-21496.
9. Piwnica-Worms D., Chiu M., Budding M., Kronauge J., Kramer R., Croop J. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res. 53:1993;977-984.
10. Luker G., Rao V., Crankshaw C., Dahlheimer J., Piwnica-Worms D. Characterization of phosphine complexes of technetium (III) as transport substrates of the multidrug resistance (MDR1) P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier. Biochemistry. 36:1997;14218-14227.
11. Ballinger J.R., Bannerman J., Boxen I., Firby P., Hartman N.G., Moore M.J. Technetium-99m-Tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. J. Nucl. Med. 37:1996;1578-1582.
12. Crankshaw C., Piwnica-Worms D.et al. Novel Tc(III)-Q-complexes for functional imaging of the multidrug resistance (MDR1) P-glycoprotein. J. Nucl. Med. 39:1998;77-86.
13. Chen W., Luker K., Dahlheimer J., Pica C., Luker G., Piwnica-Worms D. Effects of MDR1 and MDR3 P-glycoproteins, MRP1 and BCRP/MXR/ABCP on transport of Tc-99m-Tetrofosmin. Biochem. Pharmacol. 2000;. in press.
14. Ballinger J., Muzzammil T., Moore M. Technetium-99m-Furifosmin as an agent for functional imaging of multidrug resistance in tumors. J. Nucl. Med. 38:1997;1915-1919.
15. Elsinga P.H., Vaalburg W.et al. Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET. J. Nucl. Med. 37:1996;1571-1575.
16. Hendrikse N., Franssen E., van der Graaf W., Vaalburg W., de Vries E. Visualization of multidrug resistance in vivo. Eur. J. Nucl. Med. 26:1999;283-293.
17. Hendrikse N., Franssen E.et al. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier. Cancer Res. 59:1999;2411-2416.
18. Mehta B.M., Rosa E., Fissekis J.D., Bading J.R., Biedler J.L., Larson S.M. In vivo identification of tumor multidrug resistance with tritum-3-colchicine. J. Nucl. Med. 33:1992;1373-1377.
19. Mehta B., Rosa E., Biedler J., Larson S. In vivo uptake of carbon-14-colchicine for identification of tumor multidrug resistance. J. Nucl. Med. 35:1994;1179-1184.
20. Isobe T., Kida S., Misumi S. Preparation of schiff base complexes of lanthanides(III) ions. Bull. Chem. Soc. Japan. 40:1967;1862-1863.
21. 3trien'. Inorg. Chim. Acta. 25:1977;L137-L138.
22. Evans D.F., Jakubovic D.A. Water soluble hexadentate schiff-base ligands as sequestrating agents for iron(III) and gallium(III). J. Chem. Soc. Dalton Trans. 1988;2927-2933.
23. 2 amine phenol complexes of gallium and indium. Inorg. Chem. 34:1995;93-101.
24. +3 in aqueous solution. Inorg. Chem. 35:1996;715-724.
25. Green M.A., Welch M., Huffman J. Synthesis and crystallographic characterization of a gallium salicylaldimine complex of radiopharmaceutical interest. J. Am. Chem. Soc. 106:1984;3689-3691.
26. +. J. Nucl. Med. 34:1993;1127-1131.
27. Tsang B., Mathias C., Fanwick P., Green M. Structure-distribution relationship for metal-labelled myocardial imaging agents: comparison of a series of cationic gallium(III) complexes with hexadentate bis(salicylaldimine) ligands. J. Med. Chem. 37:1994;4400-4406.
28. Wey, S. (1995). Synthesis, characterization, and structure-activity relationships of gallium, indium, and copper-labeled radiopharmaceuticals for myocardial imaging with PET [Ph.D. Thesis]. Purdue University, West Lafayette, IN.
29. 2) ethylenediamine-bis[propyl(R-benzylimino)]metal(III) cations. J. Med. Chem. 39:1996;3483-3490.
30. Casiraghi G., Casnati G., Puglia G., Sartori G., Terenghi G. Selective reactions between phenols and formaldehyde. A novel route to salicylaldehydes. J. Chem. Soc. Perkin. Trans. I. 1980;1862-1865.
31. Sharma V., Beatty A., Goldberg D.E., Piwnica-Worms D. Structure of novel antimalarial gallium(III) complex with selectivity against chloroquine-resistant P. falciparum. J. Chem. Soc. Chem. Commun. 1997;2223-2224.
32. Piwnica-Worms D., Rao V., Kronauge J., Croop J. Characterization of multidrug-resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry. 34:1995;12210-12220.
33. Sharma V., Piwnica-Worms D. Metal complexes for therapy and diagnosis of drug resistance. Chem. Rev. 99:1999;2545-2560.
34. Chernoff D.M., Strichartz G.R., Piwnica-Worms D. Membrane potential determination in large unilamellar vesicles with hexakis(2-methoxyisobutyl isonitrile) technetium(I). Biochim. Biophys. Acta. 1147:1993;262-266.
35. Hyafil F., Vergely C., Du Vignaud P., Grand-Perret T. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res. 53:1993;4595-4602.
36. Schinkel A.H., Mol C.A.A.M., Wagenaar E., van Deemter L., Smit J.J.M., Borst P. Multidrug resistance and the role of P-glycoprotein knockout mice. Eur. J. Cancer. 31:1995;1295-1298.
37. Schinkel A., Borst P.et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:1994;491-502.
38. Hendrikse N., Franssen E.et al. Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography. Br. J. Pharmacol. 124:1998;1413-1418.
39. Cherry S., Phelps M.M.et al. MicroPET: a high resolution PET scanner for imaging small animals. IEEE Trans. Nucl. Sci. 44:1997;1161-1166.
40. Dahlheimer J., Crankshaw C., Marmion M., Piwnica-Worms D. Modulation of the pharmacokinetics of P-glycoprotein-targeted Tc-99m-complexes by GW0918 (GG918) in wild-type and mdr1a P-glycoprotein knock-out mice. Proc. Am. Assoc. Cancer Res. 38:1997;590.
41. Akiyama S.I., Fojo A., Hanover J.A., Pastan I., Gottesman M.M. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell Mol. Genet. 11:1985;117-126.
42. Chiu M.L., Kronauge J.F., Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured mouse fibroblasts. J. Nucl. Med. 31:1990;1646-1653.
43. Piwnica-Worms D., Jacob R., Horres C.R., Lieberman M. Transmembrane chloride flux in tissue-cultured chick heart cells. J. Gen. Physiol. 81:1983;731-748.
44. Lowry O.H., Rosenbrough W.F., Farr A.L., Randall R.J. Protein measurements with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
45. Piwnica-Worms D., Kronauge J., Chiu M. Uptake and retention of hexakis (2-methoxy isobutyl isonitrile) technetium(I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation. 82:1990;1826-1838.
46. Herman L.W., Sharma V., Kronauge J.F., Barbarics E., Herman L.A., Piwnica-Worms D. Novel hexakis(areneisonitrile)technetium(I) complexes as radioligands targeted to the multidrug resistance P-glycoprotein. J. Med. Chem. 38:1995;2955-2963.